Concepts and Applications of Conformal Prediction in Computational Drug
  Discovery
  Estimating the reliability of individual predictions is key to increase the
adoption of computational models and artificial intelligence in preclinical
drug discovery, as well as to foster its application to guide decision making
in clinical settings. Among the large number of algorithms developed over the
last decades to compute prediction errors, Conformal Prediction (CP) has gained
increasing attention in the computational drug discovery community. A major
reason for its recent popularity is the ease of interpretation of the computed
prediction errors in both classification and regression tasks. For instance, at
a confidence level of 90% the true value will be within the predicted
confidence intervals in at least 90% of the cases. This so called validity of
conformal predictors is guaranteed by the robust mathematical foundation
underlying CP. The versatility of CP relies on its minimal computational
footprint, as it can be easily coupled to any machine learning algorithm at
little computational cost. In this review, we summarize underlying concepts and
practical applications of CP with a particular focus on virtual screening and
activity modelling, and list open source implementations of relevant software.
Finally, we describe the current limitations in the field, and provide a
perspective on future opportunities for CP in preclinical and clinical drug
discovery.
